Referring back to a post in November:
When i raised the pharmacist issue with PAR people they replied in part
" Additionally, across our clinical trials, we have procedures in place for obtaining detailed feedback on patient experiences and adverse events. The information we receive is carefully evaluated by our medical and safety physicians and if indicated, may result in changes to management and monitoring to better improve patient experiences.
If you are aware of specific patient information, that individual is encouraged to meet with the physician who treated him/her to ensure event reporting is completed. "
The inference i drew was that they didn't know about the incident, maybe because it was indicated as "did not proceed".
Perhaps you or the attending physician should make a point of providing more detail?
Simon White is the investor relations manager, and could pass on any further feedback.
[email protected]
- Forums
- ASX - By Stock
- PAR
- Valuation and Targets
Valuation and Targets, page-322
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M |
Open | High | Low | Value | Volume |
22.0¢ | 23.5¢ | 22.0¢ | $66.95K | 294.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 90092 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 25858 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 90092 | 0.220 |
7 | 93958 | 0.215 |
7 | 143016 | 0.210 |
4 | 104982 | 0.205 |
6 | 89975 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 25858 | 1 |
0.240 | 40833 | 1 |
0.245 | 37318 | 1 |
0.250 | 15000 | 1 |
0.255 | 9785 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |